Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Janssen, Gliatech extend Alzheimer's disease research agreement

Oct. 27, 1997

SA-4503 offered for licensing by Santen

Oct. 27, 1997

New preclinical data presented on ACEA-1021

Oct. 27, 1997

P&U describes new ergoline derivatives for CNS disorders

Oct. 27, 1997

Histamine H3 ligands prepared by James Black Foundation

Oct. 27, 1997

Researchers at Janssen/Neurocrine Biosciences develop CRF antagonists

Oct. 27, 1997

Development of antipsychotic agent discontinued

Oct. 24, 1997

Serdolect now available in Germany for schizophrenia

Oct. 23, 1997

NeuroSearch evaluates NS-2389 in phase I

Oct. 23, 1997

GDNF reviewed; potential in Parkinson's disease analyzed

Oct. 23, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 7, 2025
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...